| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5M | -8.7% | -27.7% |
| Cost of Revenue | $358K | -22.9% | -23.0% |
| Gross Profit | $1.2M | -3.3% | -29.1% |
| R&D Expense | $684K | +7.5% | +4.8% |
| SG&A Expense | $1.4M | -16.7% | -12.9% |
| Operating Income | -$892K | +17.7% | -53.7% |
| Pre-tax Income | -$965K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.0M | -10.3% | +13.3% |
| Accounts Receivable | $960K | -2.4% | -50.3% |
| Inventory | $394K | +23.7% | +1.9% |
| Current Assets | $3.7M | -7.2% | -17.7% |
| Total Assets | $10.1M | -3.8% | +58.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.8M | — | — |
| Capital Expenditures | $7K | — | — |
| Investing Cash Flow | -$7K | — | — |
| Financing Cash Flow | $4.5M | — | — |
| Free Cash Flow | -$2.8M | — | — |
| +17.4% |
| -30.6% |
| Income Tax | $0 | — | — |
| Net Income | -$965K | +17.4% | -30.6% |
| EPS (Basic) | -$0.15 | +25.0% | +61.5% |
| $3.0M |
| -16.1% |
| -49.5% |
| Total Liabilities | $4.1M | +11.0% | -35.1% |
| Stockholders' Equity | $6.0M | -11.8% | +4443.7% |